Serum Sodium Levels as an Indicator of Clinical Severity in Patients with Decompensated Chronic Liver Disease
International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)
DOI: 10.25258/ijcpr.18.6.27 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Bhaskara Rao Uppala und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Decompensated chronic liver disease is frequently associated with electrolyte abnormalities, among which hyponatremia is an important marker of advanced circulatory dysfunction and poor prognosis.
Aim
To study serum sodium levels in patients with decompensated chronic liver disease (CLD) and to observe their clinical significance.
Methods
This prospective observational cross-sectional study was conducted at Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation from July 2023 to May 2025. Sixty patients with decompensated CLD were enrolled. Clinical evaluation, liver function tests, serum electrolytes, coagulation profile, ultrasonography abdomen, portal vein Doppler, and ascitic fluid analysis were performed. Statistical analysis was done using SPSS version 23.
Results
The mean age was 52 ± 10.50 years, and 95% were males. Alcohol was the commonest etiology (95%). The mean serum sodium level was 126.45 ± 5.66 mEq/L. Hyponatremia (serum sodium ≤130 mEq/L) was observed in 66.7% of patients. Significant associations were found between low serum sodium and ascites, portal hypertension, upper gastrointestinal bleed, coagulopathy, and hepatorenal syndrome. No significant association was observed with spontaneous bacterial peritonitis.
Conclusion
Serum sodium is a valuable and easily measurable prognostic marker in decompensated CLD and may help identify patients at greater risk of complications.
Zitieren
APA
Uppala, B. R., Sai, N. T., & Mareedu, B. (2026). Serum Sodium Levels as an Indicator of Clinical Severity in Patients with Decompensated Chronic Liver Disease. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.27
Vancouver
Uppala BR, Sai NT, Mareedu B. Serum Sodium Levels as an Indicator of Clinical Severity in Patients with Decompensated Chronic Liver Disease. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.27
BibTeX
@article{Uppala2026,
author = {Uppala, Bhaskara Rao and Sai, N. Tarun and Mareedu, Bhavani},
title = {Serum Sodium Levels as an Indicator of Clinical Severity in Patients with Decompensated Chronic Liver Disease},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {06},
doi = {10.25258/ijcpr.18.6.27}
}
EUVIMED